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Quantitative Aspects in the Assessment of
Liver Injury
byGabriel L. Plaa*
Liver function data are usually difficult to use in their original form when one wishes to com-
pare the hepatotoxic properties ofseveral chemical substances. However, procedures are available
for the conversion of liver function data into quantal responses. These permit the elaboration of
dose-response lines for the substances in question, the calculation of median effective doses and
the statistical analysis of differences in liver-damaging potency. These same procedures can be
utilized for estimating the relative hazard involved if one compares the liver-damaging potency to
the median effective dose for some other pharmacologic parameter. Alterations in hepatic
triglycerides, lipid peroxidation, and the activities of various hepatic enzymes can also be quan-
titated in adose-related manner.This permits the selection ofequitoxic doses required for certain
comparative studies and the selection of doses in chemical interaction studies. The quantitative
problems involved in low-frequency adverse reactions and the difficulty these present in the
detection ofliver injury in laboratory animals are discussed.
Conversion of Liver Function Data into Quantal
Responses
In order to compare potencies of compounds it
is necessary to establish dose-response
parameters in terms which can be statistically
analyzed. Such procedures are done routinely in
the determination of the median lethal dose
(LD50), the dose which kills 50°h ofthe population
under test. The traditional manner is to plot
along the ordinate the probit transformation of
the percentage of animals that died and to plot
the dose, or the logarithm of the dose, along the
abscissa. Similar types of transformations can be
carried out with biochemical parameters used for
assessing hepatic function.
In 1958 it was demonstrated (1) that the pro-
longation of barbiturate sleeping time induced by
liver injury could be used in such a manner. Fig-
ure 1 demonstrates the dose-response curves
which were elaborated from such data for seven
halogenated hydrocarbons with different hepato-
toxic potencies. The conversion of these data into
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quantal responses is relatively simple. What one
needs to do in the case of pentobarbital sleeping
time is to establish the mean sleeping time in a
large number of control animals. From this mean
one can calculate the standard deviation and es-
tablish the limits ofnormalcy, usually a value two
or three standard deviations removed from the
mean control response. Any value in the test
population which is larger than this upper limit of
normalcy is then considered to be an abnormal
response. In each group of animals subjected to a
single dose of halogenated hydrocarbon one de-
termines the number of animals exhibiting a nor-
mal or abnormal sleeping time. These quantal
data are then converted to percentages and plot-
ted as one normally plots lethality data. Once
achieved, these data permit the comparison ofthe
dose-response lines, tests for parallelism and
statistical analyses ofpotency differences.
While the data in Figure 1 were derived by use
of prolonged barbiturate sleeping time as the in-
dex of hepatic dysfunction, it was subsequently
demonstrated that plasma sulfobromophthalein
(BSP) retention data or elevation in serum trans-
aminase (SGPT) data could be handled in a simi-
lar manner (24). The prime prerequisite was
June 1976 39Table 1. Median effective doses for lethality and parameters
of hepatic dysfunction for six halogenated hydrocarbons in
mice.
Median effective dose, mmole/kg (IP)
24-hr BSP reten- SGPT eleva-
Compound LDso tion ED,0 tion ED,(
Carbon tetrachloride 28 0.6 0.1
Chloroform 14 9.7 2.3
1,1,1-Trichloroethane 37 27 2.5
1,1,2-Trichloroethane 3.7 2.7 1.1
Trichloroethylene 24 23 18
Tetrachloroethylene 28 32 28
a Dataobtained from Klaassen and Plaa (3).
FIGURE 1. Dose-response curve for the effect of seven
halogenated hydrocarbons on prolongation of pentobarbital
sleeping time in mice. All hydrocarbons were given sub-
cutaneously; pentobarbital sleeping time was determined 24
hr later. Redrawn from Plaa et al. (1) with permission ofthe
Williams and Wilkins Co.
that a large control population be measured and
that upper limits ofnormalcy be established.
Table 1 shows the median effective doses for
lethality (LDso), the BSP retention EDso, and the
SGPT elevation EDso. It can be seen that the two
parameters of hepatic dysfunction have EDso
values which are much smaller than the 24-hr
LDso, except for tetrachloroethylene. It should be
mentioned that the 24-hr LDso is actually a
measure of the central nervous system depress-
ing properties of the halogenated hydrocarbon
and is not a measure of lethality due to hepatic
dysfunction.
Table 2 shows that when one ranks the six
halogenated hydrocarbons, according to their
relative potencies then the 24-hr LDsois a poor in-
dex of the hepatotoxic potencies of these com-
pounds. Carbon tetrachloride appears to be one
of the least potent halogenated hydrocarbons if
one uses the LDso as the parameter; however, if
one uses BSP retention or SGPT elevation as the
parameter, carbon tetrachloride becomes the
most potent of this series. The relative potencies
for BSP and SGPT agree quite well with the
known relative hepatotoxic potencies of these
halogenated hydrocarbon solvents based on in-
dustrial experience.
While comparison of relative potencies based
on only one hepatotoxic parameter can be useful,
other types of quantitative comparisons can be
made to indicate the relative hazard involved
with exposure to such substances. Table 3 depicts
the potency ratios (LDso/EDso) for the six
halogenated hydrocarbons in question, SGPT
elevation being used as the parameter of hepatic
dysfunction. It can be seen that carbon tetra-
chloride has a potency ratio which is quite large
and quite different from those established for the
other halogenated hydrocarbons. A potency ratio
of 280 for carbon tetrachloride means that the ef-
fective dose for producing liver injury in mice is
about 1/300 the dose required to produce death
primarily by central nervous system depression.
On the other hand, for tetrachloroethylene the
potency ratio of 1.0 indicates that the dose which
produces liver injury is essentially identical to
the dose that produces death by central nervous
system depression. Table 3 shows the same type
of data generated from results using BSP reten-
tion as the parameter of dysfunction. One notices
again that carbon tetrachloride has a much larger
potency ratio than the other compounds. The
dose producing liver injury is about 1/50 of the
Table 2. Relative potency rankings ofsixhalogenated hydrocarbons in mice."
24-hrLDso BSP retention EDso SGPT elevation EDs0
1,1,2-Trichloroethane Carbon tetrachloride Carbon tetrachloride
Chloroform 1,1,2-Trichloroethane 1,1,2-Trichloroethane
Trichloroethylene Chloroform Chloroform
Tetrachloroethylene Trichloroethylene 1,1,1-Trichloroethane
Carbon tetrachloride 1,1,1-Trichloroethane Trichloroethylene
1,1,1-Trichloroethane Tetrachloroethane Tetrachloroethane
a Data obtained from Klaassen and Plaa (3). Each list progresses downward from most potent to least potent hydrocarbon.
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40Table 3. Potency ratios of six halogenated hydrocarbons for
SGPT elevation or BSP retentionin mice.
BSP-retention SGPT-elevation
potencyratio potency ratio
Compound (LDso/EDso) (LDso/EDso)
Carbon tetrachloride 45 280
Chloroform 1.5 6.4
1,1,2-Trichloroethane 1.4 3.4
1,1,1-Trichloroethane 1.4 1.5
Trichloroethylene 1.1 1.4
Tetrachloroethylene 0.9 1.0
a Calculated from data in Table 1. Data obtained from
Klaassen and Plaa (3).
dose producing death within 24 hr. With trichlo-
roethylene the dose required to produce liver in-
jury is virtually identical with the dose required
to produce death.
Potency ratios derived in this matter can be
used to acquire a quantitative assessment of the
relative hazard involved in exposures of these
various agents. In an industrial environment it is
relatively easy to determine whether the concen-
tration of carbon tetrachloride in the atmosphere
is sufficiently high to produce mild depression of
the central nervous system (dizziness, ataxia,
etc.). However it is quite difficult to determine
whether the concentration in the atmosphere is
sufficiently high to produce liver injury since this
requires a matter of days before the signs of tox-
icity develop. If an industrial environment is con-
trolled in such a manner that the concentration in
the air being breathed by the individual is suffi-
ciently low to prevent visible signs ofcentral ner-
vous system depression one has also controlled
the environment against the liver damaging
properties of a compound like trichloroethylene
since the potency ratio for this compound is
about 1. However with carbon tetrachloride, con-
trol of the environmental atmosphere for effects
on the central nervous system only does not elim-
inate the possibility that the concentration is suf-
ficiently high to produce liver injury, because of
the large potency ratio for this compound. There-
fore this type of experimental quantitative com-
parison of potency can give some indication ofthe
relative hazard that may be involved with these
substances in occupational environments.
It should be noted that the animals in these ex-
periments received the halogenated hydrocar-
bons either by the subcutaneous or the intra-
peritoneal route of administration. However,
workers exposed to these solvents usually inhale
them. Therefore one can question whether data
derived by the parenteral route ofadministration
can be useful for estimating relative hazard of in-
halation. From a theoretical standpoint the po-
tency ratio derived by the parenteral route of ad-
ministration should resemble that derived by the
inhalation route, since the pharmacological ef-
fects are manifestations of the amount of sub-
stance that has been absorbed. However, it is
known that the route of administration can affect
the amount of substance absorbed and its distri-
bution in tissues. Gehring (5) investigated this
aspect and compared the relative potencies of a
series of halogenated hydrocarbons when they
were administered by parenteral route to those
obtained when they were given by inhalation. He
found that, while there were some differences in
the absolute value of the potency ratio, the
relative rankings of the halogenated hydrocar-
bons were quite similar with both routes of ad-
ministration, indicating that even parenterally
administered compounds can give an indication
about the relative hazard involved when the
substances are given by inhalation. This is a
rather important point, since quantitative inhala-
tion studies are not particularly easy to carry
out. Often alaboratory does not have adequate in-
halation facilities to carry out such studies.
Therefore it is possible to get some idea of
relative hazard by using other routes of ad-
ministration, provided one realizes that the ab-
solute values obtained cannot be identical to
those one would obtain if proper inhalation
studies were carried out.
While this type of quantitative comparison of
potencies can be very useful, it must be realized
that quantal data say nothing about the severity
of the haptic lesion. They merely indicate
whether or not hepatic dysfunction has occurred.
Table 4 summarizes the varying degrees of se-
verity obtained for seven halogenaed hydrocar-
bons in dogs and mice when the amount of hydro-
Table 4. Severity of liver injury induced by minimal lethal
doses of seven halogenated hydrocarbons, SGPT elevation
beingused as the indexofhepatic dysfunction."
SGPT (R-F units)
Compound Dogs Mice
Carbon tetrachloride 13,000 5,500
Chloroform 5,000 1,200
1,1,2-Trichloroethane 700 130
Dichloromethane 500 nil
Tetrachloroethylene 400 nil
1,1,1-Trichloroethane 350 65
Trichloroethylene 250 90
aData obtained from Klaassen and Plaa (3, 4).
June 1976 41carbon administered was quite large and in the
lethal range (about an LD,0). One notes that the
elevation in transaminase produced by carbon
tetrachloride and chloroform is much greater
than the elevations observed with the other
hydrocarbons. This has been substantiated by
morphologic assessment, and indeed the extent of
the liver injury produced by carbon tetrachloride
and chloroform with these doses is much greater
than that produced with the other hydrocarbons
included inthe study.
While these results were obtained with sub-
stances that produced hepatic necrosis, one
should not lose sight of the fact that the same
principles can be used for measuring hyper-
bilirubinemia and cholestasis, a-Naphthylisothio-
cyanate (ANIT) produces cholestasis and hyper-
bilirubinemia in mice and rats (6,7). After having
established normal bilirubin concentrations in a
control population and establishing the upper
limits of normalcy, one can also obtain quantal
data for the presence or absence of hyperbili-
rubinemia. This is shown in Figure 2 for ANIT in
mice; one can see that the production of hyper-
bilirubinemia follows a dose-related pattern and
that the ED50 for production of hyper-
bilirubinemia is quite different from the LDso in
these animals.
course of this elevation in liver triglycerides for
four halogenated hydrocarbons in rats (8). It can
be seen that carbon tetrachloride causes a rapid
accumulation of liver triglycerides and causes a
more marked retention of triglycerides than the
other compounds studied; 1,1,1-trichloroethane
did not produce elevations in liver triglycerides.
This elevation in liver triglycerides is also dose-
dependent (Fig. 4). Such dose-response curves
can be used for making quantitative comparisons
amongseveral halogenated hydrocarbons.
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FIGURE 2. Dose-response curve for
FIGURE 3. Effect of four halogenated hydrocarbons on
hepatictriglyceride accumulation in rats. Agents were given
intraperitoneally. Redrawn from Klaassen and Plaa (8) with
permission ofPergamon Press.
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and (right) lethality in mice 24 hr after orally administered
ANIT. Dataobtained from Becker and Plaa (6).
Quantitation of Other Abnormal Hepatic
Biochemical Findings
The halogenated hydrocarbons like chloroform
and carbon tetrachloride produce an increase in
hepatic triglycerides which leads to the develop-
ment of a fatty liver. Figure 3 shows the time
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FIGURE 4. Dose-response curves for hepatic triglyceride ac-
cumulation for three halogenated hydrocarbons in rats.
Agents were given intraperitioneally; triglycerides were
measured 24 hr later. Redrawn from Klaassen and Plaa (8)
withpermission ofPergamon Press.
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42Unfortunately a number of reports in the lit-
erature which attempt to compare the relative
properties of various halogenated hydrocarbons
fail to realize that equitoxic doses have to be used
in order. to make such comparisons. In certain
types of studies, like those which deal with
mechanisms of actions, it is often necessary to
compare compounds. In this type of situation it
would seem essential that equitoxic doses, rather
than equimolar doses, be employed. Quantitation
of effects such as triglyceride accumulation can
permit one to derive equitoxic doses.
Carbon tetrachloride is known to depress glu-
cose-6-phosphatase activity in liver tissue. This
enzyme is part of the endoplasmic reticulum and
is measured in the microsomal fraction of liver
homogenates. Figure 5 demonstrates the tem-
poral pattern of the depression of glucose-6-
phosphatase activity after exposure of rats to
carbon tetrachloride (8). Such a depression in
glucose-6-phosphatase activity is also a dose-
related phenomenon and can be quantitated by
determining dose-response curves (Fig. 6).
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FIGURE 5. Effect of carbon tetrachloride, given in-
traperitoneally on hepatic glucose-6-phosphatase activity in
rats. Redrawn from Klaassen and Plaa (8) with permission of
Pergamon Press.
Another known effect of carbon tetrachloride
is the production of lipid peroxidation of
microsomal lipids. This can be measured by
following the formation of conjugated dienes in
microsomal lipids. Figure 7 shows the temporal
pattern of this lipid peroxidation following a
single dose of carbon tetrachloride (8). This
enhanced formation ofconjugated dienes has also
been demonstrated to be dose-related (Fig. 8).
The quantitative treatment of these various
biochemical parameters of hepatic dysfunction
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FIGURE 6. Dose-response curve for carbon tetrachloride on
hepatic glucose-6-phosphatase activity in rats, 12 hr after in-
traperitoneal administration. Redrawn from Klaassen ai d
Plaa (8)with permission ofPergamon Press.
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FIGURE 7. Effect of carbon tetrachloride, given in-
traperitoneally, on hepatic microsomal conjugated dienes in
rats. Redrawn from Klaassen and Plaa (8) with permission of
Pergamon Press.
can also be used to determine what types of tests
are most likely to show alterations in interaction
studies. In the rat for a 10-fold increase in dose
(0.1 to 1.0 ml/kg) of carbon tetrachloride one
finds that there is about a 4-to 5-fold difference in
the elevation in serum transaminase values (9).
From Figure 4 it is seen that there is about a 3-
fold difference in hepatic triglyceride accumula-
tion over the same dosage range. From Figure 6
it is seen that there is only about a 50% dif-
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FIGURE 8. Dose-response curve for carbon tetrachloride on
hepatic microsomal conjugated dienes in rats, 30 min after
intraperitoneal administration. Redrawn from Klaassen and
Plaa (8) with permission ofPergamon Press.
ference in the depression of hepatic glucose-6-
phosphatase activity over this dosage range, and
in Figure 8 it is seen that there is less than a 2-
fold difference in the hepatic conjugated diene
response. Therefore one would predict that rela-
tively small differences in dosage will have a
much more marked effect on transaminase activi-
ty, if this is the parameter being measured, than
they would have on the presence of conjugated
dienes or on the depression of hepatic glucose-6-
phosphatase. This has been borne out in interac-
tion studies carried out with ethanol, isopro-
panol, and carbon tetrachloride (9). The greatest
effect of the interaction was seen when serum
transaminase activity was the parameter
measured and the least effective parameter ap-
peared to be depression of hepatic glucose-6-
phosphatase activity.
chloroform alone was given was considerably less
than the number of animals showing hepatic
dysfunction when ethanol was administered pre-
viously. The same type of potentiation was
demonstrated by using BSP retention as the
quantal parameter (10).
More recently, the potentiating effects of
ethanol and isopropanol have been studies in the
rat (9). This effect is shown in Figure 9, where
elevation in serum transaminase activity is plot-
ted against the pretreatment time. It can be seen
that if ethanol was given 18 hr before carbon
tetrachloride there was a significant increase in
the transaminase elevation caused by a small
dose (0.1 ml/kg) of carbon tetrachloride. Non-
pretreated animals only exhibited an increased
SGPT of about 150 units, whereas animals
treated with ethanol 18 hr previously responded
with 500 units of activity. However, with iso-
propanol the same small dose of carbon tetra-
chloride produced sufficient damage to elevate
the transaminase activity to about 2400 units.
This marked potentiation by isopropanol relative
to that produced by ethanol has been verified by
morphologic studies. The degree of the potentia-
tion can be further seen when one compares the
response of rats to 1.0 ml/kg of carbon tetra-
chloride in the nonpretreated animals; this 10-
fold increase in carbon tetrachloride only pro-
duced about 450 units of SGPT activity whereas
1/10 of the dose given to animals pretreated with
either ethanol or isopropanol yielded values of
500 and 2400 units, respectively. However, the
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On the basis of industrial experience it was
thought that ethanol could potentiate the liver in-
jury produced by carbon tetrachloride or chloro-
form. In mice the conversion of prolongation of
barbiturate sleeping time into quantal data was
used to demonstrate the interaction between
ethanol and chloroform (10). The number of
animals exhibiting hepatic dysfunction when
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FIGURE 9. Effect of orally administered (e) ethanol and (U)
isopropanol on carbon tetrachloride-induced elevation in
serum transaminase activity, 24 hr after intraperitoneal ad-
ministration of carbon tetrachloride to rats. The challenging
dose of carbon tetrachloride was 0.1 ml/kg. Redrawn from
Traiger and Plaa (9) with permission ofAcademic Press, Inc.
Environmental Health Perspectives
o'-
-
- 4
44quantitative aspects shown in Figure 9 suggested
that the two alcohols were not necessarily
operating bythe same mechanisms.
The marked quantitative difference between
isopropanol and ethanol was investigated to try
to unravel the mechanisms involved. It was
established that, with isopropanol, its metabolic
product, acetone, also could potentiate carbon
tetrachloride liver injury (11). However with
ethanol, its metabolic product, acetaldehyde, did
not potentiate carbon tetrachloride. In other
words, with isopropanol both the parent alcohol
and its metabolic product appearedtobe involved
in the potentiation, whereas with ethanol only one
substance was involved. By quantitative compar-
isons of the dose-response curves for isopropanol
and acetone it was possible to determine the
relative contribution of acetoneintheisopropanol
interaction (11, 12). This is demonstrated in
Figure 10. It was calculated that about 80% ofthe
isopropanol was converted to acetone in the rat.
Therefore animals were subjected to varying
doses of isopropanol to determine the dose-
response relationship ofthis alcohol. Subsequent-
ly doses of acetone which would be equivalent to
the amount converted in vivo were given to
another series of rats and the dose-response
curve determined. Figure 10 shows that the
dose-response curves for acetone and isopropanol
are virtually superimposable, suggesting that the
major effect in the isopropanol interaction with
carbon tetrachloride is due primarily to the for-
mation of acetone. Once again quantitative as-
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FIGURE 10. Dose-response curves for (A) acetone and (e)
isopropanol potentiation of carbon tetrachloride-induced
elevation in serum transaminase activity 24 hr after a
challenging dose ofcarbon tetrachloride. Redrawn from Plaa
and Traiger (12)withpermission ofS. Karger AG.
sessment of hepatic dysfunction has been shown
to be useful for determiningthe relative contribu-
tion ofapair ofmixtures.
Quantitative Problems Involved in Low-
FrequencyAdverse Reactions
Cholestatic reactions that are seen with drugs
in man occur with an extremely low frequency
(13). While abnormal hepatic function can be
demonstrated inlarge numbers ofpatients taking
such drugs, only very few (1% or less) of in-
dividuals have sufficiently altered hepatic func-
tion to demonstrate the signs and symptoms of
cholestasis and jaundice. Unfortunately these
low-frequency reactions are not easily demon-
strable in laboratory animals. Therefore some
have suggested that our current toxicological
testing methods are inadequate. Table 5
demonstrates the problem as it is presented to
toxicologists. It should be remembered that the
agents that produce cholestasis do so in a manner
which appears to be unrelated to the dose.
Table 5. Number of animals required to show low frequency
adverse reactions.
Frequency, Number ofanimals
% tobe tested
1 299
0.1 2,995
0.01 29,956
0.001 299,572
aData obtained from Zbinden (14).
Therefore increasing the dose in an animal pop-
ulation does not necessarily uncover the chole-
static potential of a given drug. Zbinden (14)
has calculated the number ofanimals which would
be required to demonstrate an adverse reaction
in animal populations if the frequency of this
adverse reaction occurs with the same frequency
found in humans. From Table 5 it can be seen that
if the frequency in man is of the order of 1%, it
would be necessary to test about 300 animals in
order to have a 95% probability of getting one
animal with the lesion. If the frequency of the
adverse reaction in man is 0.1%, 300 animals
would have to be tested to have a 95% probabili-
ty of obtaining one reacting animal. If the fre-
quency were 0.01% then 30,000 animals would
have to be tested to yield one reacting animal
June 1976 45(95% probability). These calculations demon-
strate that if the adverse reaction occurs in the
animal population with the same frequency that it
occurs in humans, it is virtually impossible to
detect this type of change in the animals and also
virtually impossible to collect a sufficient number
of reacting animals to study the phenomenon. It
is quite possible that the problem ofdrug-induced
cholestasis as it is now known to occur with drugs
is a demonstration ofthis low-frequency problem.
This means that the mere increase in numbers of
animals is not the solution to current toxicological
testing procedures. This means that other types
of animal models which respond with higher fre-
quency have to be found or that other testing
parameters which appear to correlate with
cholestatic potential should be used as an index of
cholestasis. Once again we see that the quan-
titative assessment oftoxicity, this time frequen-
cy, plays an important role.
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